Furthermore, our findings demonstrated that the overexpression of ETK resulted in the upregulation of the AKT/mTOR signaling pathway in ccRCC, as shown by the elevated levels of phosphorylated AKT and phosphorylated mTOR. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.